Managing diabetes is complicated. Even with access to the best tools and technology, it requires constant blood sugar level monitoring and daily treatment in the form of medication or insulin. If corporate decisions, displacement, or conflict leave a person living with diabetes without sustained access to affordable care, diabetes can quickly become complicated and life-threatening. … Read more
Fangak County, South Sudan- When Nyasebit Chan moved to Old Fangak in Jonglei State, South Sudan, a hepatitis E outbreak was well underway. The virus affects people of all ages but is particularly risky for pregnant women and girls. A mother to two sons, Nyasebit had left her immediate family in New Fangak to support … Read more
Activists present ‘Time for $5’ petition signed by over 206,000 people asking US corporations Cepheid and Danaher to drop test prices Bali/Geneva, 12 November 2024 – At the annual TB Union Conference, taking place in Bali, Indonesia, over 70 TB activists, including Doctors Without Borders/Medecins Sans Frontieres (MSF), took the stage during the opening ceremony to … Read more
80% of people with diabetes live in low- and middle-income countries, where access to insulin pens is extremely limited due primarily to high prices. Geneva/Johannesburg, 11 November 2024 – Ahead of World Diabetes Day, Médecins Sans Frontières/Doctors Without Borders (MSF) called on pharmaceutical corporations Eli Lilly, Novo Nordisk, Sanofi, and all insulin manufacturers to take urgent action … Read more
US test maker Cepheid and parent corporation Danaher have ignored global calls for price reductions and have broken their promise from one year ago to be transparent about what it costs to make their medical tests Washington, DC, 17 October 2024 — Today, the international medical humanitarian organisation Doctors Without Borders/Medecins Sans Frontieres (MSF), alongside … Read more
Doctors Without Borders/Médecins Sans Frontières(MSF) is resuming its work in support of Tucson-based nonprofit groups that are bringing humanitarian aid to migrants and asylum seekers crossing the US-Mexico border near the Sonoran Desert, the organization announced today. Earlier this year, a small MSF team worked alongside Humane Borders, Samaritans, No More Deaths, and other local … Read more
Mumbai, 17 July 2024 – On Friday 5 July 2024, the “pre-grant opposition” filed in December 2020 by The Delhi Network of Positive People (DNP+) and a Mumbai-based tuberculosis (TB) survivor Ganesh Acharya, and supported by Médecins Sans Frontières/Doctors Without Borders (MSF) was successful: the Indian Patent Office rejected the US pharmaceutical corporation Johnson & … Read more
Geneva, 17 June 2024 – In September 2023, the US corporation Danaher, which owns diagnostics maker Cepheid, announced a price reduction of the primary GeneXpert test used to diagnose tuberculosis (TB), from US$9.98 to $7.97, amid pressure from TB activists. Since then, officials from the Ministries of Health of Sierra Leone, Ghana, Ukraine, Belarus and … Read more
Berlin, 6 June 2024: As the World Health Organization (WHO) concluded a meeting with European health officials and civil society to improve access to tuberculosis (TB) medicines in the European Union (EU)/European Economic Area (EEA), Médecins Sans Frontières/Doctors Without Borders (MSF), along with TB activists, urge European countries to maintain this momentum by taking immediate … Read more
Where are we now? This week, on 6-7 June 2024, the Board of Gavi, the Vaccine Alliance, is meeting in Geneva to approve and endorse the one-page framework for Gavi 6.0, which outlines its strategy for the five-year period from 2026-2030. Gavi, which is funded by public and private donors, was set up nearly 25 … Read more